前列腺素I2-1型干扰素轴抑制诱导髓外造血促进心梗后心脏修复
该研究在小鼠心肌梗死模型中揭示,脾脏髓外造血受PGI2-IFN轴调控:MI增强脾脏EMH,PGI2通过IP-cAMP-453p-SP1级联抑制EMH,而造血细胞特异性IP缺失则增强EMH并改善心脏恢复。
要点
- MI后脾脏EMH增强,Scf缺陷小鼠EMH缺乏加重组织损伤
- PGI2通过IP-cAMP-453p-SP1级联抑制脾脏HSPC的EMH
- 造血细胞IP缺失增强EMH并改善MI后心脏恢复
核心结论
- PGI2-IFN轴参与调控MI后脾脏EMH,为缺血性心脏损伤提供新治疗靶点。
研究设计与样本
- 构建Tcf21CreER Scfflox/flox MI小鼠模型抑制EMH,并通过流式分选GFP+造血干细胞注射测试局部炎症细胞来源。
- 采用液相色谱-串联质谱脂质组学和单细胞RNA测序分析MI后脾脏花生四烯酸代谢物及HSPC转录组。
主要发现
- MI增强EMH,表现为脾脏重量、体积及HSPC数量增加。
- Scf缺陷小鼠EMH缺乏加重MI后组织损伤。
- MI后脾脏HSPC转录组显示1型干扰素通路在造血干细胞/多能祖细胞亚群中显著抑制,1型干扰素信号缺失增强MI诱导的脾脏EMH。
- 脂质组学显示脾脏PGI2显著减少;PGI2通过IP-cAMP-453p-SP1级联抑制脾脏HSPC的EMH。
- 造血细胞特异性IP缺陷小鼠EMH增强且MI后心脏恢复改善。
临床怎么用
- 调控PGI2-IFN轴或可增强MI后脾脏EMH并促进心脏修复。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Immune cells are closely associated with all processes of cardiac repair after myocardial infarction (MI), including the initiation, development, and resolution of inflammation. Spleen extramedullary hematopoiesis (EMH) serves as a crucial source of emergency mature blood cells that are generated through the self-renewal and differentiation of hematopoietic stem/progenitor cells (HSPCs). However, how EMH responds to MI and the role of EMH in cardiac repair after MI remains unclear. METHODS: To assess the role of spleen EMH in MI, a Tcf21CreER Scfflox/flox MI mouse model with inhibited EMH was constructed. GFP+ (green fluorescent protein) hematopoietic stem cells were sorted from eGFP (enhanced GFP) mouse spleen by flow cytometry and injected into Tcf21CreER Scfflox/flox mice to test the sources of local inflammatory cells during MI. Using highly specific liquid chromatography-tandem mass spectrometry and single-cell RNA sequencing, we analyzed the lipidomic profile of arachidonic acid metabolites and the transcriptomes of HSPCs in the spleen after MI. RESULTS: We found that MI enhanced EMH, as reflected by the increase in spleen weight and volume and the number of HSPCs in the spleen. The lack of EMH in Scf-deficient mice exacerbated tissue injury after MI. Analysis of the transcriptome of spleen HSPCs after MI revealed that the type 1 interferon pathway was substantially inhibited in hematopoietic stem cell /multipotent progenitor subclusters, and the absence of type 1 interferon signaling enhanced the MI-induced spleen EMH. Lipidomics analysis revealed that prostaglandin I2 (PGI2) was markedly reduced in the spleen. PGI2 suppressed MI-induced EMH through a PGI2 receptor (IP)-cyclic adenosine monophosphate-453p-SP1 cascade in spleen HSPCs. Hematopoietic cell-specific IP-deficient mice exhibited enhanced EMH and improved cardiac recovery after MI. CONCLUSIONS: Together, our findings revealed that a PGI2-IFN axis was involved in spleen EMH after MI, providing new mechanistic insights into spleen EMH after MI and offering a new therapeutic target for treating ischemic cardiac injury.
引用
- Lv, Wang, Liu, et al. Suppression of the Prostaglandin I2-Type 1 Interferon Axis Induces Extramedullary Hematopoiesis to Promote Cardiac Repair After Myocardial Infarction. Circulation. 2025. PMID: 40289806. doi:10.1161/CIRCULATIONAHA.124.069420
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。